thiazoles has been researched along with Urge Incontinence in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alves de Oliveira, H; Araújo de Oliveira, GL; Castano Silva, TB; da Silva Pereira, D; Zanghelini, F | 1 |
| Cornu, JN | 1 |
| Barkin, J; Castro-Diaz, D; Espuna-Pons, M; Frankel, JM; Gousse, AE; Gunther, A; Herschorn, S; Martin, N; Stölzel, M; Van Kerrebroeck, P | 1 |
| Andersson, KE | 1 |
| Angulo, JC; Liu, S; Luo, X; Peral, C; Ramos, J; Rejas, J; Sánchez-Ballester, F; Snedecor, SJ; Sudharshan, L | 1 |
| Ikeda, Y; Ohkawa, S; Yamaguchi, O | 1 |
| Amarenco, G; Angulo, JC; Boerrigter, P; Cambronero, J; Chapple, C; Drogendijk, T; Høye, K; Khullar, V; Milsom, I; Radziszewski, P; Rechberger, T; Wooning, M | 1 |
| Chapple, CR; Cummings, J; Dorrepaal, C; Drogendijk, T; Kaplan, SA; Klecka, J; Martin, N; Mitcheson, D | 1 |
2 review(s) available for thiazoles and Urge Incontinence
| Article | Year |
|---|---|
Actual treatment of overactive bladder and urge urinary incontinence.
Topics: Acetanilides; Botulinum Toxins, Type A; Caffeine; Clinical Trials, Phase III as Topic; Drinking Behavior; Electric Stimulation Therapy; Electrodes, Implanted; Exercise Therapy; Female; Humans; Male; Multicenter Studies as Topic; Muscarinic Antagonists; Neurokinin-1 Receptor Antagonists; Pelvic Floor Disorders; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Therapies, Investigational; Thiazoles; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urologic Surgical Procedures | 2013 |
The use of pharmacotherapy for male patients with urgency and stress incontinence.
Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urinary Incontinence, Urge; Urological Agents | 2014 |
4 trial(s) available for thiazoles and Urge Incontinence
| Article | Year |
|---|---|
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index; Tachycardia; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2013 |
Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Quality of Life; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Young Adult | 2017 |
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Australia; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Single-Blind Method; Surveys and Questionnaires; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urination | 2013 |
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urinary Retention; Xerostomia | 2013 |
5 other study(ies) available for thiazoles and Urge Incontinence
| Article | Year |
|---|---|
Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence: The Brazilian Public Health System Perspective.
Topics: Acetanilides; Adult; Brazil; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Public Health; Thiazoles; Urinary Incontinence, Urge; Urological Agents | 2020 |
Mirabegron for overactive bladder syndrome.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Female; Humans; Male; Muscarinic Antagonists; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2013 |
When major trials mean minor efficacy.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Clinical Trials as Topic; Humans; Research Design; Thiazoles; Urinary Incontinence, Urge | 2016 |
mirabegron (BETMIGA⁰). Poorly effective in urge urinary incontinence.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Female; Humans; Pregnancy; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Urinary Incontinence, Urge | 2016 |
Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective.
Topics: Acetanilides; Benzhydryl Compounds; Cost-Benefit Analysis; Delivery of Health Care; Female; Humans; Male; Middle Aged; Spain; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2016 |